ANKRD30BP3

Across TCGA pan-cancer cohorts, ANKRD30BP3 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated ANKRD30BP3 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher ANKRD30BP3 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated ANKRD30BP3 expression acts as an unfavorable survival marker, although some lineages such as LUSC and ESCA show a favorable association.

LUSC, KIRP, and UVM are the cancer types where ANKRD30BP3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	DFS	Tertile	III,IV	0.570	0.222	.002	58	view →
KIRP	DFS	Tertile	All	0.326	0.667	<.001	51	view →
UVM	OS	Tertile	All	0.220	0.917	<.001	45	view →
UCEC	OS	Tertile	All	0.815	0.891	.005	30	view →
ESCA	DFS	Median	III,IV	0.462	0.230	.002	26	view →
COAD	OS	Tertile	All	0.713	0.884	.003	24	view →
CHOL	DFS	Tertile	All	0.746	0.225	.023	19	view →
SKCM	OS	Quartile	III,IV	0.576	0.356	.009	15	view →
LIHC	DFS	Tertile	All	0.410	0.578	.013	15	view →
LGG	OS	Tertile	All	0.847	0.917	.004	13	view →
GBM	DFS	Tertile	All	0.312	0.201	.014	13	view →
BLCA	DFS	Quartile	II,III,IV	0.525	0.637	.012	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

ANKRD30BP3–LUSC (DFS)

Open the LUSC breakdown →